1,552 results on '"Khan, Muhammad Shahzeb"'
Search Results
2. Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials
3. Chitosan-Based Adsorbents and Catalysts for Removal of Toxic Pollutants from Water and Wastewater
4. Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
5. Nanomaterials for the Catalytic Degradation and Detection of Microplastics: A Review
6. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis
7. Antero-lateral vs. antero-posterior electrode position for cardioversion of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
8. Employee Satisfaction and Engagement Are Crucial for Organizational Success
9. Contributors
10. Chitosan-based composites for oil-contaminated water treatment
11. Green adsorbents and solvents in food analysis
12. Environmental impact of nanomaterials
13. Electrospun fibers: promising materials for oil water separation
14. The need for increased pragmatism in cardiovascular clinical trials
15. Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials
16. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure
17. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
18. Nano-based remediation strategies for micro and nanoplastic pollution
19. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
20. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
21. Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis
22. Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
23. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
24. Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events
25. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure
26. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
27. Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study
28. Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis
29. Safety and feasibility of same-day discharge for catheter ablation of atrial fibrillation: a systematic review and meta-analysis
30. Representation of women, older patients, ethnic, and racial minorities in trials of atrial fibrillation
31. Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis
32. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
33. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
34. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
35. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
36. Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure
37. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018)
38. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials
39. Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results
40. Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials
41. Cardiovascular implications of COVID-19 versus influenza infection: a review.
42. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
43. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
44. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure
45. Predicting and preventing heart failure in type 2 diabetes
46. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
47. Hospital at Home as a Treatment Strategy for Worsening Heart Failure
48. In Silico modeling and exploration of new acceptor molecules with enhanced power conversion efficiency for high-performance organic solar cell applications
49. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
50. Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.